Robert Auciaux - 09 May 2022 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
11 May 2022, 17:11:29 UTC
Prior SEC filing
27 Apr 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joshua Foukas, Attorney-in-Fact
Filing notes and source

Key filing fact

Robert Auciaux filed Form 4 for USANA HEALTH SCIENCES INC (USNA) on 11 May 2022.

Key facts

  • This page summarizes Robert Auciaux's Form 4 filing for USANA HEALTH SCIENCES INC (USNA).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 11 May 2022, 17:11.

Change

  • Previous filing in this sequence was filed on 27 Apr 2022.
  • Current net transaction value: -$238,091.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

USNA transaction

Common Stock

Options Exercise

Transaction value
Shares
+10,630
Change %
+1625%
Price
Shares after
11,284
Date
09 May 2022
Ownership
Direct
Footnotes
F1
USNA transaction

Common Stock

Tax liability

Transaction value
-$238,091
Shares
-3,192
Change %
-28%
Price
$74.59
Shares after
8,092
Date
09 May 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

USNA transaction Derivative

Deferred Stock Units

Options Exercise

Transaction value
Shares
-10,630
Change %
-100%
Price
Shares after
0
Date
09 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,630
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Robert Auciaux is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of common stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSU's were granted.

Footnote F2

The reporting person's service on the issuer's Board of Directors terminated on February 9, 2022. Per the individual's equity grant agreements, the issuer is distributing shares of common stock equal to the number of DSU's previously granted to the reporting person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .